144 related articles for article (PubMed ID: 15116102)
1. Expression of CD109 in human cancer.
Hashimoto M; Ichihara M; Watanabe T; Kawai K; Koshikawa K; Yuasa N; Takahashi T; Yatabe Y; Murakumo Y; Zhang JM; Nimura Y; Takahashi M
Oncogene; 2004 Apr; 23(20):3716-20. PubMed ID: 15116102
[TBL] [Abstract][Full Text] [Related]
2. CD109 expression in squamous cell carcinoma of the uterine cervix.
Zhang JM; Hashimoto M; Kawai K; Murakumo Y; Sato T; Ichihara M; Nakamura S; Takahashi M
Pathol Int; 2005 Apr; 55(4):165-9. PubMed ID: 15826242
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
4. CD109 represents a novel branch of the alpha2-macroglobulin/complement gene family.
Solomon KR; Sharma P; Chan M; Morrison PT; Finberg RW
Gene; 2004 Mar; 327(2):171-83. PubMed ID: 14980714
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
[TBL] [Abstract][Full Text] [Related]
6. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.
Hagikura M; Murakumo Y; Hasegawa M; Jijiwa M; Hagiwara S; Mii S; Hagikura S; Matsukawa Y; Yoshino Y; Hattori R; Wakai K; Nakamura S; Gotoh M; Takahashi M
Pathol Int; 2010 Nov; 60(11):735-43. PubMed ID: 20946523
[TBL] [Abstract][Full Text] [Related]
7. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.
Zhang L; Ding F; Cao W; Liu Z; Liu W; Yu Z; Wu Y; Li W; Li Y; Liu Z
Clin Cancer Res; 2006 Mar; 12(5):1639-46. PubMed ID: 16533792
[TBL] [Abstract][Full Text] [Related]
8. CD109 expression in basal-like breast carcinoma.
Hasegawa M; Moritani S; Murakumo Y; Sato T; Hagiwara S; Suzuki C; Mii S; Jijiwa M; Enomoto A; Asai N; Ichihara S; Takahashi M
Pathol Int; 2008 May; 58(5):288-94. PubMed ID: 18429827
[TBL] [Abstract][Full Text] [Related]
9. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
10. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
[TBL] [Abstract][Full Text] [Related]
11. CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells.
Hasegawa M; Hagiwara S; Sato T; Jijiwa M; Murakumo Y; Maeda M; Moritani S; Ichihara S; Takahashi M
Pathol Int; 2007 May; 57(5):245-50. PubMed ID: 17493171
[TBL] [Abstract][Full Text] [Related]
12. Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
Yoshinaga K; Mimori K; Inoue H; Kamohara Y; Yamashita K; Tanaka F; Mori M
Int J Oncol; 2008 Sep; 33(3):453-9. PubMed ID: 18695873
[TBL] [Abstract][Full Text] [Related]
13. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
[TBL] [Abstract][Full Text] [Related]
14. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.
Zhang H; Zhao Q; Chen Y; Wang Y; Gao S; Mao Y; Li M; Peng A; He D; Xiao X
Thorax; 2008 Apr; 63(4):352-9. PubMed ID: 18364444
[TBL] [Abstract][Full Text] [Related]
15. VCC-1, a novel chemokine, promotes tumor growth.
Weinstein EJ; Head R; Griggs DW; Sun D; Evans RJ; Swearingen ML; Westlin MM; Mazzarella R
Biochem Biophys Res Commun; 2006 Nov; 350(1):74-81. PubMed ID: 16989774
[TBL] [Abstract][Full Text] [Related]
16. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
Ishikawa N; Takano A; Yasui W; Inai K; Nishimura H; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Cancer Res; 2007 Dec; 67(24):11601-11. PubMed ID: 18089789
[TBL] [Abstract][Full Text] [Related]
17. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
18. Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma.
Fatima S; Chui CH; Tang WK; Hui KS; Au HW; Li WY; Wong MM; Cheung F; Tsao SW; Lam KY; Beh PS; Wong J; Law S; Srivastava G; Ho KP; Chan AS; Tang JC
Int J Mol Med; 2006 Jan; 17(1):159-70. PubMed ID: 16328025
[TBL] [Abstract][Full Text] [Related]
19. Expression of bone morphogenetic proteins in human lung carcinomas.
Langenfeld EM; Bojnowski J; Perone J; Langenfeld J
Ann Thorac Surg; 2005 Sep; 80(3):1028-32. PubMed ID: 16122479
[TBL] [Abstract][Full Text] [Related]
20. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
